MedPath

Pain relief in breast surgery

Phase 4
Not yet recruiting
Conditions
Malignant neoplasm of nipple and areola, (2) ICD-10 Condition: C508||Malignant neoplasm of overlappingsites of breast, (3) ICD-10 Condition: C502||Malignant neoplasm of upper-innerquadrant of breast,
Registration Number
CTRI/2022/11/047142
Lead Sponsor
ESIPostgraduate Institute of Medical Sciences and Research
Brief Summary

Patients undergoing breast mastectomy surgery experience moderate to severe postoperative pain. In this study, after the patient has been anaesthetised, he/she will be given either a block with local anaesthetic drug under ultrasound guidance in the back muscles or in the front muscles. After the surgery is completed and the effect of anaesthesia is reversed, the patient will be shifted to recovery room, where he/she will be assessed for pain and analgesic requirement. Medications for pain will be administered as per the need of patient.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

All patients undergoing elective mastectomy surgery.

Exclusion Criteria

•Patient refusal •Contraindications to regional anaesthesia •Known allergy to local anaesthetics •Bleeding diathesis •Use of any anti-coagulants •Patient on chronic analgesics.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Total postoperative analgesic consumption24hrs after surgery
Secondary Outcome Measures
NameTimeMethod
Postoperative pain assessment: Numeric pain Rating score (NRS) at rest and movement.Total requirement of rescue analgesia (Fentanyl).

Trial Locations

Locations (1)

ESI-PGIMSR, BASAIDARAPUR, NEW DELHI

🇮🇳

West, DELHI, India

ESI-PGIMSR, BASAIDARAPUR, NEW DELHI
🇮🇳West, DELHI, India
DR DIVYA SETHI
Principal investigator
9891230700
divyasth@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.